{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:58:19Z","timestamp":1773298699743,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejso.2020.02.017","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T02:40:15Z","timestamp":1582080015000},"page":"976-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Alessandra","family":"Buja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"De Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Baracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Vecchiato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Del Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Guzzinati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Saia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Riccardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.02.017_bib1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2133.2012.11125.x","article-title":"Melanoma incidence and mortality in Europe: new estimates, persistent disparities","volume":"167","author":"Forsea","year":"2012","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.017_bib2","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2020.02.017_bib3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.017_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/jdv.13110","article-title":"Stage-specific direct healthcare costs in patients with cutaneous malignant melanoma","volume":"30","author":"Lyth","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejso.2020.02.017_bib5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.2016.77","article-title":"Cost of care for cancer patients in England: evidence from population-based patient-level data","volume":"114","author":"Laudicella","year":"2016","journal-title":"Br J Canc"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.017_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2340\/00015555-2830","article-title":"Estimation of direct melanoma related costs by disease stage and by phase of diagnosis and treatment according to clinical guidelines","volume":"98","author":"Buja","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejso.2020.02.017_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.amepre.2012.07.031","article-title":"Melanoma treatment costs: a systematic review of the literature, 1990-2011","volume":"43","author":"Guy","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejso.2020.02.017_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D353F8Q915","article-title":"Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages","volume":"15","author":"Alexandrescu","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ejso.2020.02.017_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0190-9622(98)70195-1","article-title":"An estimate of the annual direct cost of treating cutaneous melanoma","volume":"38","author":"Tsao","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.017_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/CMR.0000000000000372","article-title":"Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)","volume":"27","author":"Grange","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2020.02.017_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jdv.15315","article-title":"Cost-of-illness of melanoma in Europe \u2013 a systematic review of the published literature","volume":"33","author":"Krensel","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejso.2020.02.017_bib12","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.ejca.2012.03.003","article-title":"Economic impact of healthcare resource utilization patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study)","volume":"48","author":"Johnston","year":"2012","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.02.017_bib13","first-page":"91","article-title":"The cost of unresectable stage III or stage IV melanoma in Italy","volume":"31","author":"Maio","year":"2012","journal-title":"J\u00a0Exp Clin Canc Res"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.017_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2016.68.4308","article-title":"Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of melanoma","volume":"35","author":"Watts","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.017_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1245\/s10434-008-0164-z","article-title":"The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma","volume":"16","author":"Morton","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"36","key":"10.1016\/j.ejso.2020.02.017_bib16","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.017_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bjd.12095","article-title":"Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register","volume":"168","author":"Lyth","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejso.2020.02.017_bib18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejso.2018.11.022","article-title":"Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases","volume":"45","author":"Piazzalunga","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.017_bib19","author":"World Health Organization"},{"key":"10.1016\/j.ejso.2020.02.017_bib22","series-title":"High-resolution registry of melanoma and care pathways monitoring in the Veneto Region","author":"Guzzinati","year":"2018"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.017_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.soc.2014.12.001","article-title":"Current staging and prognostic factors in melanoma","volume":"24","author":"Bartlett","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"issue":"9","key":"10.1016\/j.ejso.2020.02.017_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.2006.08.1463","article-title":"Identification of high-risk patients among those diagnosed with thin cutaneous melanomas","volume":"25","author":"Gimotty","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.017_bib25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.017_bib26","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/1097-0142(19940501)73:9<2324::AID-CNCR2820730914>3.0.CO;2-5","article-title":"Prognostic factors in thin cutaneous malignant melanoma","volume":"73","author":"Mansson-Brahme","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.017_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10434-000-0262-z","article-title":"Incidence of sentinel node metastasis in patients with thin primary melanoma (\u2264 1 mm) with vertical growth phase","volume":"7","author":"Bedrosian","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.017_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10434-000-0251-2","article-title":"Sentinel node metastasis from thin melanomas with vertical growth phase","volume":"7","author":"Thompson","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.017_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PRS.0000000000004395","article-title":"Vertical growth phase as a prognostic factor for sentinel lymph node positivity in thin melanomas: a systematic review and meta-analysis","volume":"141","author":"Appleton","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.02.017_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/1097-0142(20010301)91:5<983::AID-CNCR1088>3.0.CO;2-J","article-title":"Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV","volume":"91","author":"Owen","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.017_bib31","series-title":"The World Health Report 2002: reducing risks, promoting healthy life","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.ejso.2020.02.017_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jval.2011.10.009","article-title":"Lifetime cost effectiveness of skin cancer prevention through promotion of daily sunscreen use","volume":"15","author":"Hirst","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.ejso.2020.02.017_bib33","article-title":"Cost-effectiveness of a melanoma screening programme using using whole disease modelling","author":"Buja","year":"2019","journal-title":"J\u00a0Med Screen"},{"issue":"4","key":"10.1016\/j.ejso.2020.02.017_bib35","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1245\/s10434-017-6325-1","article-title":"Long-term survival of patients with thin (T1) cutaneous melanomas: a breslow thickness cut point of 0.8 mm separates higher-risk and lower-risk tumors","volume":"25","author":"Lo","year":"2018","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320301190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320301190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:58Z","timestamp":1760060038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320301190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0748798320301190"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.02.017","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}